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Abstract 1 
Human primordial germ cells (hPGCs), the precursors of sperm and eggs, 2 
originate during week 2-3 of early postimplantation development1. Using in 3 
vitro models of hPGC induction2-4, recent studies suggest striking 4 
mechanistic differences in specification of human and mouse PGCs5. This 5 
may partly be due to the divergence in their pluripotency networks, and 6 
early postimplantation development6-8. Since early human embryos are 7 
inaccessible for direct studies, we considered alternatives, including 8 
porcine embryos that, as in humans, develop as bilaminar embryonic 9 
discs. Here we show that porcine PGCs (pPGCs) originate from the 10 
posterior pre-primitive streak competent epiblast by sequential 11 
upregulation of SOX17 and BLIMP1 in response to WNT and BMP 12 
signalling. Together with human and monkey in vitro models simulating 13 
peri-gastrulation development, we show conserved principles for epiblast 14 
development for competency for PGC fate, followed by initiation of the 15 
epigenetic programme9-11, regulated by a balanced SOX17–BLIMP1 gene 16 
dosage. Our combinatorial approach using human, porcine and monkey in 17 
vivo and in vitro models, provides synthetic insights on early human 18 
development. 19 
 20 
  21 
3 
 
First, we sought the origin of porcine PGCs (pPGCs) in ~E9.5-E16 peri-gastrulating 1 
embryos. At ~E9.5–E10, key pluripotency genes NANOG, OCT4 and SOX2 are 2 
detected in the epiblast of bilaminar embryos (Fig. 1a). In ~E11 pre-primitive streak 3 
(PS) stage embryos with an incipient anterior-posterior axis (Extended Data Fig. 1a), 4 
BRACHYURY (T) expression is evident in the posterior pseudo-stratified epiblast cells, 5 
together with NANOG and OCT4, but SOX2 is downregulated (Fig. 1b).  6 
 7 
In the midline of early-PS stage embryos (~E11.5-E12), we see the first cluster of 8 
SOX17 positive (+ve) cells in the posterior end of the nascent PS (arrows in Fig. 1c,d; 9 
Extended Data Fig. 1b); most of these express BLIMP1, except for those at the 10 
anterior end. Expression of SOX17 precedes BLIMP1; NANOG is retained and 11 
upregulated in SOX17/BLIMP1 +ve pPGCs (Fig. 1d; Extended Data Fig. 1b). In 12 
~E12.5-E13.5 embryos, pPGCs exhibit co-expression of SOX17, BLIMP1, NANOG, 13 
TFAP2C, OCT4, and pPGC cell surface marker Sda/GM212, but have low levels of T 14 
(Fig. 1e, Extended Data Fig. 1c,d). This pPGC cluster of ~60 SOX17/BLIMP1 +ve cells 15 
located at the border between embryonic and extraembryonic tissues in early-PS stage 16 
embryos (~E12), increases to >300 PGCs by ~E15.5 (Extended Data Fig. 2a-c). A 17 
6-hour (h) pulse of EdU labelling shows that DNA synthesis ceases soon after the 18 
detection of Sda/GM2 epitope (Fig. 1f, Extended Data Fig.2d), indicating that the 19 
sharp increase in pPGCs is likely due to the additional recruitment from T+ve competent 20 
progenitors. Thereafter, pPGCs enter quiescence and pause prior to migration, as in 21 
mice13 (Fig. 1f, Extended Data Fig. 2c). Notably, PRDM14 expression in pPGCs is 22 
weak and apparently cytoplasmic (Extended Data Fig. 1f), while SOX2 is undetectable 23 
(Extended Data Fig. 2e,f). 24 
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 1 
Initiation of the germline-specific epigenetic program9,14 is evident in nascent pPGCs 2 
with a global reduction in 5-methylcytosine (5mC) (Extended Data Fig. 3b,c) and 3 
concomitant enrichment of 5-hydroxymethylcytosine (5hmC) (Fig. 1g,h). Consistently, 4 
UHRF1 is downregulated (Fig. 1i) and TET1 is upregulated (Extended Data Fig. 3a). 5 
Progressive reduction in H3K9me2 and G9a expression is also evident (Extended Data 6 
Fig. 3b,c) and global DNA demethylation follows as pPGCs migrate towards the gonads 7 
(Extended Data Fig. 3d). Expression of SOX17, BLIMP1, TFAP2C, OCT4 and NANOG 8 
continues in pPGCs (arrowheads in Fig. 1e, Extended Data Fig. 2e,f), as seen in 9 
equivalent hPGCs in vivo4,9. Thus, pPGCs originating from peri-gastrulation porcine 10 
epiblast exhibit close similarities with hPGCs following sequential SOX17 and BLIMP1 11 
expression, and the onset of the epigenetic program4,9.   12 
  13 
To determine when porcine epiblasts gain competency for pPGC fate, we isolated 14 
epiblast discs away from the hypoblast and trophectoderm at different stages of 15 
development (Fig. 2a,b,d,e). We exposed them to cytokines, including BMP2 or 16 
43,4(henceforth called Cytokines or Cy) for 64h to induce pPGCs ex vivo (Fig. 2f). While 17 
no response was seen in ~E10.5-E11 early bilaminar disc epiblasts, an efficient 18 
induction of pPGCs occurs in epiblasts from ~E11.5 pre-PS embryos, with 19 
co-expression of SOX17, BLIMP1, NANOG, OCT4 and TFAP2C (Fig. 2g,h, Extended 20 
Data Fig. 3e). Note a strong BMP2/4 signal from the posterior pre-streak and early PS 21 
pig embryos in vivo15,16 (Fig. 2a), with nuclear pSMAD1/5/8 localisation in the posterior 22 
epiblast (Fig. 2c). BMP4 inhibitor (LDN193189) abrogates (0/5) pPGC induction (Fig. 23 
2g, Extended Data Fig. 3e). The competency for pPGC fate wanes during early-PS 24 
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stage concomitantly with the onset of gastrulation and mesendoderm differentiation (Fig. 1 
1c). WNT signalling from the posterior pre-PS epiblast is also apparently important (Fig. 2 
2a), as evidenced by the high proportion of T +ve cells, a downstream target on WNT17, 3 
during pPGC induction (Fig. 1b). A WNT inhibitor (WNTi) diminishes pPGC induction, 4 
but not in early-PS stage epiblast when they are already competent for pPGC fate (Fig. 5 
2g, Extended Data Fig.3e). Expression of T in response to WNT is a common feature 6 
of competency for germ cell fate3,4,17. 7 
Next, since we cannot examine early human embryos directly, we decided to simulate 8 
human peri-gastrulation development and induce hPGC fate in vitro. We established an 9 
in vitro model with human pluripotent stem cells (hPSC) for mesendoderm (ME) and 10 
peri-gastrulation development18-20 (Fig. 3a). These hPSCs in a defined conventional 11 
medium (henceforth; Conv-hPSCs, see Methods), are probably equivalent to the 12 
pre-gastrulating porcine epiblast21. To follow gain and loss of competency for hPGCs 13 
specification in the course of ME differentiation, we used cells with a sensitive 14 
NANOS3-tdTomato (NT) reporter (see Extended Data Fig. 4). By checking for hPGCs 15 
induction by Cytokines at 6h intervals (Fig. 3a), we observed a peak of competency at 16 
~12h during ME differentiation, declining thereafter (Fig. 3b,d), illustrating a step-wise 17 
transition in cell states. PGC-competent cells show moderate upregulation of PS 18 
markers; T, MIXL, GSC, EVX1 and EOMES, and a slight reduction of SOX2 (Fig. 3e, 19 
Extended Data Fig. 5a, b). At 18h onwards, there is upregulation of late PS markers; 20 
TBX6, MESP1/2, and SNAIL (SNAI1/2), which triggers epithelial-mesenchymal 21 
transition, occurring during gastrulation22 (Extended Data Fig. 5b). The response of 22 
cells to signalling also changes, since BMP2/4 now induces mesodermal cells 23 
(Extended Data Fig. 5b, e-h), while Activin A and a BMP inhibitor efficiently induces 24 
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definitive endoderm (DE)18 (Fig. 3c,d. Extended Data Fig. 5e-h). Thus, from ~12h, 1 
onwards, the ME precursors (or Pre-ME) are competent for PGC fate, but from ~18h 2 
(ME), competency for PGC declines, with concomitant gain of competency for 3 
DE/mesoderm fates (Fig. 3a-c).   4 
 5 
Both WNT and ACTIVIN/NODAL signalling are necessary for competency for hPGCs in 6 
12h Pre-ME (Extended Data Fig. 5c). Inhibition of BMP during ME differentiation 7 
dramatically reduces the efficiency of hPGC induction, suggesting a role for 8 
endogenous BMP (Extended Data Fig. 5d).  Addition of BMP during Pre-ME(12h) 9 
however does not affect hPGC competency, but it favours differentiation into lateral 10 
mesoderm (LM) at 24h, which originates from mid/posterior PS (Extended Data Fig. 11 
5e-h). By contrast, DE differentiation occurs in the anterior PS as seen in PS-stage 12 
porcine embryos (arrowheads in Fig 1d, Extended Data Fig.1c), suggesting that BMP 13 
confers posterior characteristics to PS during gastrulation (Extended Data Fig. 5i). The 14 
combined evidence from porcine embryos, and simulations in in vitro with Conv-hPSCs, 15 
shows progressive and transient acquisition of competency for hPGC, followed by 16 
competency for DE/mesoderm.  17 
 18 
To test if this model fapplies to non-human primates, we used Cynomolgus monkey 19 
PSCs (cmPSCs) to induce ME differentiation (Extended Data Fig. 6a,b). Remarkably, 20 
cmPSCs also show a temporal gain of competency for cmPGC fate at ~12h during ME 21 
differentiation, and thereafter DE and mesoderm at 24h (Extended Data Fig. 6c-f). A 22 
recent study suggests that cmPGCs originate from the epiblast derived nascent amnion, 23 
but also potentially from the posterior epiblast23; a dual origin is however also possible. 24 
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A detailed molecular analysis of amnion is important, since SOX17 and BLIMP1 also 1 
have roles elsewhere, including extraembryonic tissues24,25, which exhibit great 2 
developmental diversity and less developmental constrain than epiblast26. Further 3 
traceable analysis of in vivo non-human primate embryo, and potentially of human 4 
embryos in vitro is merited. 5 
  6 
Next, we examined the combinatorial roles of the key transcription factors considering 7 
that SOX17 is the key regulator of both hPGC and DE (Fig. 3d)4,26. Ectopic expression 8 
of SOX17 in Pre-ME at 12h induces hPGCs resulting in NT/OCT4/BLIMP1+ve cells, but 9 
in ME at 24h it induces FOXA2+ve (DE) efficiently (Fig. 3f,g). During the induction of 10 
hPGCs in Pre-ME by BMP (Extended Data Fig. 7a,b), we first detect SOX17 at 12h, of 11 
which ~30-40% show co-expression with BLIMP1, but not TFAP2C (Extended Data Fig. 12 
7c,d), as in the pig embryo (Extended Data Fig. 1e). TFAP2C is detected at ~18h, as 13 
the number of SOX17/BLIMP1/TFAP2c+ve cells increases progressively. These 14 
putative hPGCs eventually form a cluster in the middle of embryoids by 48h (Extended 15 
Data Fig. 7b,c,e). At 12h onwards NANOG expression increases progressively in 16 
SOX17/BLIMP1+ve cells (Extended Data Fig. 7e,f). However, unlike in mouse27, 17 
NANOG alone cannot induce hPGCs (Extended Data Fig. 8a-c), and PRDM14 18 
expression appears weak2,4, and might be cytoplasmic in E14 pPGCs (Extended Data 19 
Fig. 1f) in hPGCs in vivo5. PRDM14 is critical for mouse PGC fate and epigenetic 20 
reprogramming28, but its role, if any, in hPGCs and pPGCs requires further studies. 21 
 22 
Next, we tested SOX17, BLIMP1 and TFAP2C individually and in combination for the 23 
induction of hPGCs in the reversibly PGC-competent hPSCs (Comp-hPSC)4, with the 24 
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NT reporter and inducible SOX17, BLIMP1 and TFAP2C transgenes (Extended Data 1 
Fig. 4c-j, see Methods, and Extended Data Fig. 8d-g). BLIMP1 and TFAP2C 2 
individually and together elicit a negligible response after 2 days, while SOX17 alone 3 
produces a modest response, with or without TFAP2C (Fig. 4a). Remarkably, SOX17 4 
with BLIMP1 produce a strong response, and a large proportion of NT-positive cells (Fig. 5 
4a), suggesting that they act synergistically and rapidly (within ~24h), compared to 96h 6 
for Cytokines to induce a similar response (Fig. 4b,c). This response is preceded by 7 
downregulation of SOX229 and upregulation of ‘naïve’ pluripotency genes including 8 
KLF4 and TFCP2L1, as in hPGCs in vivo9 (Fig. 4e, Extended Data Fig. 8h). The 9 
response to SOX17-BLIMP1 is otherwise similar to that induced by Cytokines as judged 10 
by global RNA-seq (Fig. 4d, Extended Data Fig. 8i,j).  11 
 12 
For further mechanistic insights, we induced ectopic SOX17 with or without BLIMP1 13 
expression in SOX17 null Comp-hPSC4 (Extended Data Fig. 9a, Extended Data Fig. 14 
10a,b). Although SOX17 initiates hPGC fate, there is also a significant increase in 15 
FOXA2 expression, an endodermal gene (Fig. 4f). Accordingly, FACS-purified cells 16 
show FOXA1, FOXA2 and HNF1 expression, alongside PGC markers, OCT4, NANOG, 17 
BLIMP1 and TFAP2C (Extended Data Fig. 9b), and the cell surface marker CXCR4 18 
shared by both endoderm19 and PGC in humans (Extended Data Fig. 9c,d). This likely 19 
occurs due to high ectopic SOX17 gene dosage exceeding the levels induced by BMP 20 
in wildtype Comp-hPSC (Extended Data Fig. 9b, e-h), without a proportionate increase 21 
in BLIMP1 (Extended Data Fig. 9i). Notably, BLIMP1 represses endodermal genes 22 
during hPGC specification9. Indeed, concomitantly high BLIMP1 and SOX17 induce 23 
hPGCs robustly and rapidly while suppressing endoderm genes (Fig. 4g, Extended 24 
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Data Fig. 10c), and also initiate the germline-specific epigenetic program9, with 1 
downregulation of DNMT3A, DNMT3B and UHRF1, and upregulation of TET2 2 
(Extended Data Fig. 8k), as in pPGCs (Extended Data Fig. 3b,d).  3 
  4 
The ex vivo peri-gastrulation porcine embryos, and in vitro mimics for human and 5 
monkey development exemplify conserved principles for PGC specification in the 6 
context of epiblast development in flat disc embryos (Fig. 4h). We show how SOX17 7 
likely regulates both PGCs and DE.  We propose that signalling followed by epigenetic 8 
priming of regulatory elements might confer competency for PGC fate, and thereafter 9 
DE/mesoderm, as an integral part of epiblast development program towards 10 
gastrulation. Remarkably, SOX17-BLIMP1 are necessary and sufficient for inducing 11 
PGCs, and for initiating the germline-specific epigenetic program. Once specified, 12 
PGCs are irreversibly committed to the germline fate (Extended Data Fig. 2e,f, 13 
Extended Data Fig. 10d,e).  Notably, our integrated approach provides insights on 14 
early human development and cell fate decisions. 15 
 16 
 17 
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Main Figure Legends 1 
Fig.1 Specification of PGCs in gastrulating porcine embryos  2 
Serial sections with immunostainings: 3 
a. Bilaminar disc embryo (~E9.5-E10); Arrowhead marks the 4 
epiblast/trophectoderm boundary. Scale bar: 20 µm.  5 
b. Pre-primitive streak embryo (Pre-PS; ~E11) . Scale bar: 10 µm. 6 
c. Early primitive streak embryo (Early-PS; ~E11.5-E12) with SOX17 and 7 
BLIMP1 expression. Close-up (dashed lines) shows four SOX17 +ve and 8 
BLIMP1 -ve cells (arrows). Dashed lines highlight SOX17/BLIMP +ve cells. The 9 
hypoblast is SOX17/BLIMP1 +ve. Scale bar: 10 µm. 10 
d. Primitive streak embryo (PS; ~E12) with a pPGC cluster showing SOX17 and 11 
NANOG expression. Four SOX17 +ve cells without NANOG in the most anterior 12 
pPGC cluster (arrows in middle image). The right most image (arrows) point to 13 
five SOX17 +ve and BLIMP1 -ve cells. Arrowheads show anterior PS with 14 
SOX17 +ve definitive endoderm cells. Dashed lines highlight SOX17/BLIMP +ve 15 
cells. Scale bar: 10 µm. Inset shows the whole embryo.  16 
e. Late primitive streak embryo (Late-PS; ~E12.5-E13.5) with a pPGC cluster 17 
(arrow) showing NANOG, SOX17, TFAP2C, BLIMP1, T and Sda/GM2 18 
expression. Arrowheads: early migratory pPGCs. Scale bar: 25 µm.  19 
A<–>P; anterior-posterior axis 20 
f. Quantification of EdU incorporation in pPGCs and somatic cells. Numbers 21 
denote analyzed cells. 22 
g. Sagittal section of E14.5 embryo immunostained for OCT4 and 5hmC, and 23 
the pPGC cluster (white square) . Arrows: migratory PGCs. Scale bar: 20 μm. 24 
12 
 
h. Quantification of 5hmC.in analyzed cells. (Mann-Whitney: * p<0.01). 1 
i. Immunostaining for UHRF1 in E14 embryos. Dashed line delimits the pPGC 2 
cluster. Scale bar: 20 μm. 3 
 4 
 5 
Fig.2 Competence for pPGC specification  6 
a. Representation of porcine epiblasts and signaling for pPGC induction.  7 
b. Dissected epiblasts. Scale bar: 0.25 mm.  8 
c. Serial sections of a Pre-PS embryo showing pSMAD1/5/8 and T. Close-up 9 
(dashed lines) of posterior epiblast cells (arrows) with nuclear pSMAD but no T. 10 
Scale bar: 20 μm. 11 
d. Epiblasts culture for 64 h.  12 
e. Epiblasts prior to culture. Scale bar: 0.5mm.  13 
f. Epiblasts after 64 h culture.  14 
g. Scatter plot for the triple positive pPGCs staining.   15 
h. Triple immunostaining of epiblasts. Scale bar: 20 μm.  16 
WNTi (WNT inhibitor); BMPi (BMP inhibitor) 17 
 18 
 19 
Fig.3 Simulating of human peri-gastrulation and hPGC competency  20 
a. Schematics showing progressive gain and loss of competency for hPGCs.  21 
b. Induction of hPGCs (% NT/AP +ve cells) in day 4-5 embryoids. 22 
c. Induction of of definitive endoderm (DE: (% CXCR4 +ve cells)) at 12h–24h of 23 
during ME differentiation. 24 
13 
 
d. Immunostaining of hPGCs induced from Pre-ME(12h) and of DE from 1 
ME(24h). Dashed lines: SOX17/OCT4 +ve hPGCs. Scale bar: 50 μm. 2 
e. Gene expression (RT-qPCR) changes during ME induction. 3 
f. Induction of hPGCs (%NANOS3-tdTomato/AP +ve cells) from Pre-ME(12h) or 4 
ME(24h). Pre-ME are competent for hPGCs in response cytokines or SOX17, 5 
but ME are not. 6 
g. Immunostaining of day4 embryoids from Pre-ME(12h) or ME(24h). SOX17 in 7 
Pre-ME induced OCT4/BLIMP1 +ve hPGCs (dashed line), but in ME, it induced 8 
DE  (BLIMP1/FOXA2 +ve) cells. Scale bar: 50 μm. 9 
 10 
 11 
Fig.4 Induction of hPGCs by SOX17-BLIMP1 and combined representation 12 
of hPGCs and pPGCs specification   13 
a. Induction of hPGCs by transcription factors in Comp-hPSCs: SOX17-BLIMP1 14 
induce hPGCs  15 
b. Day1–4 embryoids with NANOS3-tdTomato (NT) reporter respond to ectopic 16 
SOX17 and BLIMP1 with or without cytokines. 17 
c. Induction of hPGCs (% NT/AP +ve cells) shown in Fig.4b. 18 
d. t-SNE analysis of RNA-seq data. 19 
e. Heat map of representative gene expression includes previous data4. 20 
f. Day 4 embryoids induced by cytokines. Dashed line indicates positive signals. 21 
Arrowheads: OCT4/BLIMP1 +ve hPGC expressing FOXA2. Scale bar: 50 μm. 22 
g. SOX17 and BLIMP1 gene dosage is critical during hPGC specification: 23 
BLIMP1 represses SOX17-induced endodermal genes. 24 
14 
 
h. Representation of human germ cell origin and program based on in vitro 1 
simulations from hPSCs and in vivo origin of pPGCs in porcine embryos.  2 
  3 
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Methods 1 
Porcine embryo collection 2 
All the procedures involving animals have been approved by the School of 3 
Biosciences Ethics Review Committee, The University of Nottingham. Embryos 4 
were collected from crossbred Large White and Landrace sows (2-3 years old) 5 
between days 10 and 16 after artificial insemination (AI). Embryos from days 6 
10-16 (embryonic day (E) 10-16; (bilaminar (n=4); Pre-PS (n=7), Early-PS (n=6); 7 
PS (n=10), Late-PS (n=13), ~E14 (n=8), ~E16 (n=10)) were flushed from the 8 
uterine horns with 30-40 ml warm PBS (supplemented with 1% FCS). Embryos 9 
older than E15 were retrieved by cutting the uterus longitudinally from the 10 
antimesometrial side and picked with forceps. Embryos at each stage were 11 
retrieved from multiple sows. All embryos were grouped by stages and washed 12 
with DMEM-F12 (Thermo Fisher Scientific) + 20% knockout serum replacement 13 
(KSR: Thermo Fisher Scientific) supplemented with 25 mM HEPES (wash 14 
medium, WM) and transported to the laboratory in a portable incubator at 15 
38.5°C. 16 
 17 
 18 
Immunohistochemistry of porcine embryos and gonads 19 
Embryos were processed as previously described30. Briefly, embryos and 20 
gonads were fixed in 2.5% paraformaldehyde (PFA) in PBS overnight (ON) at 21 
4ºC and transferred to methanol at -20°C for long term storage. For less 22 
advanced embryos (E9.5-10.5) 2% agarose blocks were made before 23 
embedding in wax. Agarose blocks were then trimmed and dehydrated with 24 
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increasing concentrations of ethanol (70%, 90% and 100%) for 2 h each step. 1 
After dehydration, blocks were processed in xylene followed by hot paraffin wax 2 
for 2 h and then cooled down in a metal mold. E14-15 embryos and gonads were 3 
dehydrated, embedded and processed as described above. All paraffin blocks 4 
were cut into 4 µm thick sections and mounted onto SuperFrost plus slides. 5 
Sections were air dried ON and immunohistochemistry was conducted 6 
subsequently. For cryo-sections, fixed embryos were incubated in 30% 7 
sucrose/PBS ON at 4ºC prior to mounting in OCT compound. Cryo-sections 8 
were cut at 6 µm onto Superfrost plus glass slides. Sections were left to air dry 9 
for 1-2 h before IF. Unused slides were kept at -80°C in air tight containers. 10 
 11 
 12 
Immunofluorescence staining of porcine embryos 13 
Sections were dewaxed with xylene for 30 min and rehydrated with decreasing 14 
concentrations of ethanol (100%, 90% and 70%) and transferred to PBS for 15 15 
min. Antigen retrieval was then performed by boiling the slides in 0.01M Citrate 16 
Buffer (PH 6.0) for 10 min. Sections were permeabilized with 1% Triton-X100 in 17 
PBS for 15 min. Triton-X100 was washed three times for 5 min each, and 18 
blocking solution (PBS supplemented with 5% BSA or 10% Donkey serum/5% 19 
BSA/PBS) was added for 1-1.5 h. After blocking, sections were incubated with 20 
the desired primary antibody (see Supplementary Table 2) ON at 4°C in a 21 
humidified chamber. Slides were then washed three times with 0.1% 22 
Tween-20/PBS. Finally slides were incubated with fluorescent (TRITC, Cy3 23 
Alexa Fluorophore 488, 555, 568 and/or 647; eBioscience, Abcam, Thermo 24 
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Fisher Scientific)-conjugated secondary antibodies for 40 min at room 1 
temperature (RT). Slides were mounted with Fluoroshield with DAPI (Sigma) 2 
and sealed with nail varnish. Slides were kept at -20 °C until observed. 3 
 4 
 5 
Porcine epiblast cultures and quantification of PGC induction 6 
Embryos collected 11.5 days post AI were dissected under a dissecting 7 
microscope as described previously31. Trophectoderm and primitive endoderm 8 
were carefully removed with forceps and pure epiblasts were placed in 9 
pre-incubated in GK15 medium supplemented with individual inhibitors (i), 10 
including 10 µM WNTi (IWR-1-endo, Selleckchem), and 100 nM BMPi 11 
(LDN193189, Sigma,). GK15 medium is composed of GMEM (Thermo Fisher 12 
Scientific) supplemented with 15% KSR, 0.1 mM 2-mercaptoethanol (Thermo 13 
Fisher Scientific), 0.1 mM NEAA (Thermo Fisher Scientific), 1 mM sodium 14 
pyruvate (Sigma), 100 U/ml Penicillin- 0.1 mg/ml Streptomycin (Sigma), and 2 15 
mM L-Glutamine (Sigma). After 30 min incubation with the inhibitors, cytokines 16 
were supplemented to the final concentration of 500 ng/ml BMP4 (R&D systems), 17 
1mg/ml hLIF (Peprotech) and 200 ng/ml SCF (R&D systems). Epiblasts 18 
collected from two independent batches of animals and from 4 animals each 19 
time were grouped by stage of development (bilaminar, Pre-PS, Early-PS) and 20 
randomly distributed into three treatment groups. After 64 h incubation in a low 21 
oxygen incubator at 38.5ºC they were fixed in 2.5% PFA at 4ºC ON. After 22 
washing in PBS they were incubated in 30% sucrose/0.0025% sodium azide at 23 
4ºC ON and then mounted in OCT compound as described above. IF was 24 
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carried out with the antibodies listed in Supplementary Table 2 with 1 
fluorescent-conjugated secondary antibodies.  2 
All immunostained sections of single epiblasts were imaged at 100x 3 
magnification at antibody-specific wavelengths. NANOG-positive cells could be 4 
split into two categories; high expression and lower expression, based on 5 
immunofluorescence intensity. Image acquisition was performed using 6 
SimplePCI capture software and the Cell Counter application of Fiji was used to 7 
mark protein of interest and NANOG-high cells. Separate fluorophore images 8 
were overlaid and cells marked as positive for all three proteins of interest were 9 
counted. Only robustly stained cells were considered positive. No statistical 10 
methods were used to predetermine sample size. Mann-Whitney test was used 11 
to test for significance. 12 
 13 
 14 
Wholemount In situ hybridization 15 
RNA in situ hybridization (ISH) was carried out as previously described15. Briefly, 16 
embryos (NP (n=2); 3-5S (n=3); 6-8S (n=3)) were rehydrated in decreasing 17 
concentrations of methanol and then washed in PBS-T (PBS + 0.1% Tween-20). 18 
Next, embryos were equilibrated in (1:1) PBST:Hybridisation buffer (HB: 19 
Formamide: 50%, 2xSSC (pH5), EDTA (5mM, pH8), 0.05 mg/ml Yeast RNA, 20 
0.2% Tween20, 0.5% CHAPS, 0.1 mg/ml Heparin) for at least 10 min, and then 21 
transferred to HB before incubating at hybridisation temperature (HT) for a 22 
minimum of 2 h. After incubation, HB containing pig OCT4 probe was added and 23 
incubated ON. The following day the probe was removed and embryos were 24 
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washed 3-5 times with wash buffer (WB: 50% Formamide, 1xSSC (pH5), 0.1% 1 
Tween20) at HT, and then equilibrated with (1:1) WB:MABT solution (MABT 2 
solution:  100 mM Maleic acid, 150 mM NaCl, 0.005% Tween 20) before 3 
washing with MABT solution at RT. The embryos were then blocked with MABT 4 
and of 2% blocking reagent (Roche) for 1 h followed by blocking solution with 5 
MABT, 2% blocking reagent and 10% normal goat serum for at least 2 h. The 6 
blocking solution was then replaced with a 1:2000 dilution of anti-Dig-AP Fab 7 
fragments (Roche) and incubated overnight with gentle agitation at 4ºC. 8 
Embryos were rinsed in MABT several times before the development step with 9 
NBT/BCIP. After color reaction embryos were washed with 5xTBST (TBST: 0.7 10 
M NaCl, 0.01 M KCl, 0.125 M Tris (pH7.5), 0.5% Tween20) solution. The colour 11 
reaction was repeated until signal was detected. Once the colour reaction was 12 
satisfactory, the embryos were re-fixed with 4% PFA for 1 h, rinsed in PBST and 13 
observed under a microscope. 14 
 15 
 16 
EdU labelling 17 
Embryos collected (n=7) were rinsed in WM before 6 h incubation in 10 uM EdU 18 
at 38.5ºC. After rinsing the embryos were fixed in 4% PFA for 2 h and then 19 
transferred to 1% PFA for long term storage. Embryos were processed for 20 
immunohistochemistry as described above, except that the EdU staining 21 
protocol was performed following manufacturer instruction (Click-iT EdU, 22 
Invitrogen) prior to addition of primary antibodies used for co-labelling.        23 
 24 
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 1 
Cell culture 2 
NANOS3-mCherry hPSC, SOX17KO hPSC, SOX17KO+iS hPSC lines were 3 
established previously4. NANOS3-tdTomato hPSC line was newly generated by 4 
gene targeting (See Vector construction and gene Introduction). A 5 
cynomolgus monkey PSC (cmPSC) line (MF12 embryonic stem cells (ESCs)) is 6 
kindly gifted from E. Curnow, Washington National Primate Research Centre. 7 
Undifferentiated Conv-hPSC were maintained on vitronectin (Thermo Fisher 8 
Scientific)-coated plate in Essential 8 medium32 (Thermo Fisher Scientific) 9 
according to manufacturer’s protocol.  Cells were passed every 3-5 days using 10 
0.5 mM EDTA/PBS without breaking cell clumps.  11 
Undifferentiated Comp-hPSC were maintained on Mitomycin-C treated or 12 
irradiated mouse embryonic fibroblast (MEF) (purchased from MTI-GlobalStem 13 
or prepared in house) in knockout DMEM (Thermo Fisher Scientific) 14 
supplemented with 20% KSR, 0.1 mM NEAA, 0.1 mM 2-mercaptoethanol, 100 15 
U/ml Penicillin- 0.1 mg/ml Streptomycin, 2 mM L-Glutamine, 20 ng/ml human LIF 16 
(Stem Cell Institute, university of Cambridge (SCI)), 8 ng/ml bFGF (SCI), 1 ng/ml 17 
TGF1 (Peprotech), 3 M GSK3i (CHIR99021,Miltenyi Biotec), 1 M ERKi 18 
(PD0325901,Miltenyi Biotec), 5 M p38i (SB203580,TOCRIS bioscience), and 5 19 
M JNKi (SP600125, TOCRIS bioscience), as reported4,33.  Cells were passed 20 
every 2-4 days using TrypLE express or 0.25% trypsin/EDTA (Thermo Fisher 21 
Scientific).  Before harvesting Comp-PSC on MEF, 10 M of ROCKi (Y-27632, 22 
TOCRIS bioscience) was added into the medium. 23 
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Undifferentiated cmPSC were maintained on Mitomycin-C treated or irradiated 1 
MEF in DMEM/F-12 (Thermo Fisher Scientific) supplemented with 20% KSR, 2 
0.1 mM NEAA, 0.1 mM 2-mercaptoethanol, 100 U/ml Penicillin- 0.1 mg/ml 3 
Streptomycin, 2 mM L-Glutamine, 20 ng/ml bFGF (SCI). Before differentiation, 4 
cmPSC were maintained on MEF in Essential 8 medium supplemented with 5% 5 
KSR, 2.5 M WNTi (IWR-1; Tocris) at least for 2 passage. Cells were passed 6 
every 3-4 days using 0.25% trypsin/EDTA (Thermo Fisher Scientific). Before 7 
harvesting cmPSC on MEF, 10 M of ROCKi (Y-27632, TOCRIS bioscience) 8 
was added into the medium. 9 
For ME induction and subsequent DE/LM induction, we optimized published 10 
protocol18,34,35 with slight modification. For the basal medium, we used aRB27 11 
medium which is composed of Advanced RPMI 1640 Medium (Thermo Fisher 12 
Scientific) supplemented with 1% B27 supplement (Thermo Fisher Scientific), 13 
0.1 mM NEAA, 100 U/ml Penicillin- 0.1 mg/ml Streptomycin, 2 mM L-Glutamine. 14 
For ME induction, trypsinized Conv-hPSC were seeded on vitronectin-coated 15 
dish at 200,000 cells/well in 12 well plate and cultured in ME induction medium 16 
for 6-36 h as indicated in the figures. ME induction medium was composed of 17 
aRB27 medium supplemental with 100 ng/ml Activin-A (SCI), 3 M GSK3i and 18 
10 M of ROCKi. For DE induction, ME induction medium was replaced to DE 19 
induction medium after washing with PBS once and cells were cultured for 20 
further 2-3 days. DE induction medium was composed of aRB27 medium 21 
supplemented with 100 ng/ml Activin-A and 0.5 M BMPi (sigma). For LM 22 
induction, ME induction medium was replaced to LM induction medium after 23 
washing with PBS once and cells were cultured for further 1 day. LM induction 24 
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medium was composed of aRB27 medium supplemented with 100 ng/ml BMP2 1 
(SCI), 2.5 M WNTi (IWR-1) and 10 M TGFi (SB 431542; Tocris) . 2 
Embryoids were formed according to previous report4.  Briefly, Conv- or 3 
Comp-hPSCs, Pre-ME or ME were trypsinized into single cells and harvested 4 
into Corning® Costar® Ultra-Low attachment multiwell 96 well plate (Sigma) or 5 
PrimeSurface 96V plate (S-BIO) at 4000 cells/well in GK15 medium or aRB27 6 
medium.  To improve the cell aggregation, in some experiments, we added 7 
0.25% (v/v) poly-vinyl alcohol (sigma) in the basal medium, according to 8 
published protocol36. For hPGC induction with Cytokines, 500 ng/ml BMP4 or 9 
BMP2 (SCI), 10 ng/ml human LIF (SCI), 100 ng/ml SCF, 50 ng/ml EGF (R&D 10 
Systems), and 10 M ROCKi were added to GK15 medium or aRB27 medium.  11 
Notably, an use of aRB27 medium for the basal medium improved the efficiency 12 
of hPGC induction, especially, when we used the Pre-ME cells (see Extended 13 
Data Fig. 4i,j). A detailed protocol of the in vitro differentiation system described 14 
above is also available at Protocol Exchange37. 15 
For induction of exogenous transgenes, 100 uM Dexamethasone (Sigma), 0.5 16 
ug/ml Doxycycline (Sigma) and/or 0.5 uM Shiled-1 (Clontech) were added to the 17 
medium. 18 
 19 
 20 
Vector construction and gene introduction 21 
For construction of NANOS3-tdTomato knock-in targeting vector, 5’ and 3’ arms 22 
amplified from NANOS3-mCherry knock-in targeting vector4, 23 
rox-PGK-Purotk-rox amplified from pL1L2-PGKpurotk (a kind gift from SCI), 24 
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MC1-promoter driven DTA cassette amplified from pMC1-DTA, were cloned into 1 
pBluescript KS(+) (Stratagene) with an in-fusion HD cloning kit (Takara Bio). For 2 
efficient gene targeting, we used the CRISPR/Cas9 system. Guide RNAs 3 
targeting around the stop codon sequence of NANOS3 genes 4 
(5’-caccgAGCCTCCTAGGTGGACATGG-3’, 5’- 5 
aaacCCATGTCCACCTAGGAGGCTc-3’) were cloned into pX330 (Addgene) or 6 
eSpCas9(1.1) (Addgene). For construction of pCAG-Dre-IRES-Hygromycin, 7 
puromycin resistance gene in pCAGGS-Dre-IRES-Puro was replaced to 8 
hygromycin resistance gene. For construction of Dox/Shiled-1 inducible system, 9 
SOX17 cDNA without stop codon amplified from cDNA of hPGC and 10 
Destabilized-domain amplified from pBMN YFP-FKBP (Addgene) were cloned 11 
into PiggyBAC vector used previously38.  For construction of Dox-inducible 12 
system, Tet3G amplified from pCMV-Tet3G (Clonetech) was cloned into 13 
PiggyBAC vector which contains CAG-promoter and IRES- neomycin-resistance 14 
gene.  TRE3G cassette amplified from pTRE3G (Clonetech), human BLIMP1 15 
cDNA amplified from TRE-Tight BLIMP1-EGFP38 ,human NANOG cDNA 16 
amplified from pEP4-E02S-CK2M-EN2L (Addgene)  and human TFAP2C 17 
cDNA amplified from hPGC were cloned into PiggyBAC vector.  All fragments 18 
were amplified by PCR using PrimeSTAR MAX or PrimeSTAR GXL DNA 19 
polymerase (Takara Bio) according to the manufacturer's protocol.   20 
For gene targeting of NANOS3-tdTomato reporter, WIS2 male hESC and H9 21 
female hESC lines were used. For the gene targeting method, electroporation or 22 
lipofection was carried out as described before4. In brief, for electroporation, 1~5 23 
x 10e6 Comp-hPSCs suspended in PBS were mixed with targeting vector and 24 
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CRISPR/Cas9 plasmid was transferred to a Gene Pulser cuvette (Bio-Rad).  1 
Electroporation was carried out using Gene Pulser equipment (Bio-Rad).  For 2 
lipofection, reverse transfection was carried out.  2 x 10e5 Comp-hPSCs were 3 
suspended in 100-200 l of Opti-MEM containing targeting vector, 4 
CRISPR/Cas9 plasmid and lipofectamine 2000 (Thermo scientific) complex, and 5 
left them for 5 min at room temperature.  After electroporation or lipofection, 6 
PSCs were seeded onto 4 drug resistant (DR4) MEF (GlobalStem or SCI) and 7 
48 h later, 0.5ug/ml puromycine (Sigma) was added to the culture medium for 8 
selection. After the selection, puromycin resistant hPSC colonies were picked up 9 
and judged correct targeting by PCR using following primers (Primer F1; 10 
5’-GGGGCCAGTCTAACTAGGTGTG-3’, Primer R1; 11 
5’-GGTCTTCCTGGAAATCCAGCCG-3’, Primer R2; 5’- 12 
TGCCGGTGCCATGCCCCAGGAACA-3’ see Extended Data Fig. 4a, b). The 13 
targeted clones were expanded and then used for excision of Rox-flanked 14 
PGK-Purotk by transient transfection of pCAG-Dre-IH.  After selection with 25 15 
ug/ml hygromycin B and subsequently with 0.2 uM FIAU, colonies were picked 16 
up and judged the excision by adding puromycin or PCR using following primers 17 
(Primer F2;   5’-CCGTCCCATGCACGTCTTTATC-3’, Primer F3; 18 
5’-GAGGGCAGAGGAAGTCTGCTAACA-3’, Primer R3; 5’- 19 
GGTCTTCCTGGAAATCCAGCCG-3’ see Extended Data Fig. 4a, b).  In the 20 
representative clone derived from Wis2 hESC used in this study, G-banding 21 
karyotype analysis was performed at Medical Genetics Laboratories, Cambridge 22 
University Hospitals NHS Foundation Trust following their standard protocols, 23 
and the normal karyotypes were confirmed (20 out of 20 cells).. All clones 24 
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showed correlation of NANOS3-tdTomato and TNAP expression by FACS 1 
analysis (representatives are shown in Exteneded Data Fig. 4d-f). We also 2 
confirmed NANOS3-tdTomato +ve cells are specifically expressing the other 3 
PGC markers by immunostaining (Exteneded Data Fig. 4g). Notably, 4 
fluorescence of NANOS-tdTomato was brighter than NANOS3-mCherry which 5 
we made in previous report4 (Exteneded Data Fig. 4h). 6 
For gene introduction using PiggyBAC system, reverse transfection was 7 
carried out.  2 x 10e5 SOX17 KO Comp-hPSCs, NANOS3-tdTomato 8 
Comp-hPSCs were suspended in 100-200 l of Opti-MEM containing plasmids 9 
and lipofectamine 2000 (Thermo scientific) complex, and left them for 5 min at 10 
room temperature.  The cells were seeded on DR4 MEF at several different 11 
concentrations, and then 48 h later, drugs for selection were added to the culture 12 
medium. 13 
 14 
 15 
Quantitative reverse transcription PCR (RT-qPCR) 16 
Total RNA was extracted using PicoPure® RNA Isolation Kit (Thermo Fisher 17 
Scientific) and cDNA was synthesized using QuantiTect Reverse Transcription 18 
Kit (QIAGEN) according to manufacturer’s protocols. RT-qPCR were performed 19 
and analyzed as described previously39 and the primers sequences used in the 20 
paper are listed in Supplementary Table 3. Values normalized to GAPDH and 21 
relative to control samples (Comp-hPSC or hPGC) are shown in the figures.  22 
Error bars are mean ± SD from technical triplicate with two experiments. 23 
 24 
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 1 
Immunofluorescence staining of cells and cryo-section of embryoids  2 
Cells were cultured on -Slide 8 well (ibidi) and fixed in 4% PFA for 10 min at 3 
room temperature.  Embroids were fixed in 4% PFA for 2-4 h or ON at 4℃ and 4 
embedded in OCT compound for frozen sections.  Each sample was incubated 5 
with primary antibodies for 1-2 h at RT or ON at cold room and with 6 
fluorescent-conjugated secondary antibodies for 1 h at RT.  Antibodies used 7 
here are listed on Supplementary Table 2.  After antibody treatment, samples 8 
were stained with DAPI (Sigma) to mark nuclei and were observed under 9 
confocal laser scanning microscopy.   10 
 11 
 12 
Flow cytometry analysis 13 
PSCs, Embryoids, DE and LM were trypsinized with 0.25% trypsin/EDTA at 37℃ 14 
for 5-15 min and were stained with Alexa-488 or 647 conjugated anti-TNAP 15 
antibody (BD Bioscience), PerCP-Cy5.5 conjugated anti-CXCR4 antibody 16 
(Biolegend), PE-Cy7 conjugated anti-PDGFRa antibody (Biolegend) and/or 17 
Alexa-647 conjugated anti-CD38 antibody and subjected to FACS LSR Frotessa 18 
cytometry (BD Bioscience). FACS data were analyzed by Flowjo software. 19 
 20 
 21 
Western blot analysis 22 
Western blot analysis was carried out as described before4. Briefly, whole-cell 23 
extracts were prepared by day 4 embryoids in lysis buffer composed of 50mM 24 
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Tris-HCl (pH7.5), 0.15M NaCl, 0.1% SDS, 1% Triton X-100, 1% Sodium 1 
deoxycholate and cOmplete  mini EDTA free (Roche Applied Science, 2 
Penzberg, Germany). After electrophoresis, proteins were transferred to 3 
nitrocellulose membranes. Membranes were incubated in Western Blocking 4 
Reagent (Roche Applied Science) and treated with antibodies. Primary 5 
antibodies against SOX17 (goat IgG; R&D systems, see Supplementary Table 6 
2), and H3 (rabbit IgG; Abcam ab1791) were used. Horseradish 7 
peroxidase-conjugated secondary antibodies against goat or mouse IgG were 8 
added (Dako, Life technologies). After antibody treatment, blots were developed 9 
using ECL Western Blotting Detection System (GE Healthcare). 10 
 11 
 12 
Preparation of RNA-sequencing (RNA-seq) libraries 13 
Total RNA (5 ng) was reverse transcribed and amplified into cDNA using 14 
Ovation RNA-Seq System V2 (Nugen). Amplified cDNA was sonicated into 250 15 
bp by Covaris S220 Focused-ultrasonicators. Subsequently, RNASeq library 16 
was generated with 500 ng of fragmented cDNA using Ovation Rapid DR 17 
Multiplex System (Nugen). Library was quantified by qPCR using KAPA Library 18 
Quantification Kit (Kapa Biosystems). Libraries were subjected to single-end 50 19 
bp sequencing on HiSeq 2500 sequencing system (Illumina). Every 4 indexed 20 
libraries were multiplexed to one lane of a flowcell, resulting in >40 millions 21 
single end reads per sample 22 
 23 
 24 
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Bioinfomatics analysis 1 
Adapter-and quality-trimmed RNA-seq reads were mapped to the human 2 
reference genomes (UCSC GRCh37/hg19) using TopHat2 3 
(http://ccb.jhu.edu/software/tophat, version: 2.0.13) guided by ENSEMBL 83 4 
gene models. Raw counts per transcripts were obtained using featureCounts, 5 
only the longest transcript per gene was kept. Replicates were evaluated, raw 6 
counts were normalized, and the differential expression of transcripts was 7 
statistically evaluated by the R Bioconductor DESeq2 package 8 
(www.bioconductor.org). Expression-normalized transcript counts were further 9 
normalized by transcript length (per kB). Transcript annotations in all 10 
bioinformatics analyses were based on ENSEMBL (Release 83) considering 11 
protein coding, long-noncoding RNA and processed transcripts. Hierarchical 12 
clustering was performed with the R hclust function using the Ward’s method. 13 
Principal components were computed by singular value decomposition with the 14 
R princomp functioned on scaled DESeq-normalized expression levels. Only the 15 
80% most highly expressed transcripts were used for clustering and principal 16 
component analysis. t-statistic Stochastic Neighbor Embedding (t-SNE) analysis 17 
was performed using R Rtsne package with default parameters and “perplexity = 18 
3”. Gene set enrichment analysis (GSEA) was performed with the R phenoTest 19 
package on RNAseq data (log2(normalized counts)). hPGC-specific genes were 20 
defined as follows: (1) upregulated in week 7 male hPGC over gonadal somatic 21 
cells (log2(fold change) >3 and adjusted p value <0.05); and (2) upregulated in 22 
d4 hPGC+Cy over comp-hPSC in our previous study4; and (3) upregulated in 23 
week 7 male hPGC over comp-hPSC. 24 
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 1 
 2 
Data availability  3 
RNA-seq data have been deposited in Gene Expression Omnibus (GEO) under 4 
accession number GSE85378. All other data are included within the paper, 5 
source data and Supplementary Information. 6 
 7 
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Extended Data Figure Legends 1 
Extended Data Fig.1 Expression of key germ cell genes in early pPGCs.  2 
a. Representation of a mouse, pig and human embryos before gastrulation  3 
b. Sections of Early-PS and PS stage embryo showing SOX17, BLIMP1, 4 
NANOG and OCT4. Yellow dashed insets show cells at high magnification and 5 
white dashed lines mark SOX17 +ve and/or BLIMP1 -ve cells. Scale bar: 20 µm. 6 
c. PS (~E12) stage embryo with a cluster of pPGCs (arrow) with multiple 7 
combinations of PGC gene expression (SOX17, BLIMP1, NANOG, TFAP2C, 8 
OCT-4, Sda/GM2 and mesoderm gene, T). Arrowheads at the anterior streak 9 
point to primitive endoderm (SOX17/BLIMP1+ve and NANOG negative cells. 10 
Scale bar: 20 μm. 11 
d. Late-PS; (~E12.5-E13.5) embryo with a pPGC cluster (arrow) showing 12 
NANOG, SOX17 (split color image of Fig.1e), BLIMP1, and T expression. 13 
Arrowheads mark early migratory PGCs in the primitive endoderm. Scale bar: 25 14 
µm.  15 
e. E14 embryo stained for SOX17, BLIMP1, and TFAP2C. Yellow dashed insets 16 
show cells at high magnification and white dashed lines mark SOX17/BLIMP1 17 
+ve and TFAP2C -ve cells. Scale bar: 20 µm. 18 
f. Immunostaining for PRDM14 co stained with Sda/GM2 and SOX17 in E14 19 
(pPGC cluster) embryos and E26 gonads. Arrows point to pPGCs in the gonad. 20 
Scale bar: Scale bar: 20 µm. 21 
 22 
 23 
Extended Data Fig.2 Proliferation and development of early pPGCs. 24 
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a. OCT4 RNA in situ hybridization identifies the pPGC cluster (arrow) in the 1 
posterior end of ~E13.5-E15.5 embryos. Insets show whole embryos. 2 
b. Wholemount OCT4 IHC of a porcine embryo. Dashed square marks the area 3 
shown at higher magnification on the top right. Arrow points to the pPGC cluster. 4 
Bottom right: Cross section of the embryo (line in the wholemount image) shows 5 
migratory pPGCs (red cells).  6 
c. Number of pPGCs at different stages as indicated. 7 
d. Immunostaining of EdU labelled embryos at the indicated stages with different 8 
antibody combinations identifying the PGCs. The pPGC cluster is highlighted 9 
with dashed white line. Arrows show SOX17/EdU +ve and SOX17/BLIMP1/EdU 10 
+ve cells. Scale Bar: 20 μm. 11 
e. Immunostained migratory pPGCs (arrows); inset show cells at higher 12 
magnification. 13 
f. Immunostained gonadal pPGCs.  14 
 15 
 16 
Extended Data Fig.3 Epigenetic reprogramming in pre- and early migratory 17 
pPGCs, and key germ cell markers in migratory pPGC and cultured porcine 18 
epiblast. 19 
a. A cluster of pPGCs (dashed line) at ~E13 stained for TET1 and OCT4. Scale 20 
bar: 20 µm. 21 
b. Serial sections of E14 embryos immunostained for different epigenetic 22 
markers combined with BLIMP1, NANOG and SOX17. Dashed lines highlight 23 
pPGC clusters. Scale bar: 20 µm. 24 
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c. Quantification of 5mC and H3M9me2 in embryos of different stages. Numbers 1 
of cells analyzed are indicated. (* p<0.01; Mann-Whitney test) ).   2 
d. Serial sections of ~E16 embryos showing migratory pPGCs immunostained 3 
for the indicated epigenetic marks. Scale bar: 20 µm. 4 
e. Triple immunostaining of epiblasts cultured under different conditions. Scale 5 
bar: 10 μm. 6 
 7 
 8 
Extended Data Fig.4 Characterization of NANOS3-tdTomato (NT) reporter 9 
hPSC 10 
a. Targeting strategy for making NANOS3-tdTomato reporter. 11 
b. Representative genotyping of targeted clones using genomic DNA. 12 
c. Conventional (Conv) and PGC-competent (Comp) hPSCs states are 13 
reversible; the latter is equivalent to Pre-ME (12h at ME induction). Conv-hPSCs 14 
are cultured in Essential 8 medium on vitronectin coated dishes (see Methods). 15 
Comp-hPSCs are cultured in the hPSC medium containing inhibitor(i)s (GSK3i, 16 
ERKi, p38i, JNKi) on MEF (see Methods). 17 
d. NT reporter Conv- and Comp-hPSC, and day 1-4 embryoids induced with or 18 
without Cytokines. 19 
e. FACS pattern and % NT/AP +ve cells shown in Extended Data Fig. 4d. 20 
f. FACS pattern and % NT/AP +ve cells in multiple clones derived from Wis2 or 21 
H9 hESC lines. 22 
g. Immunostaining of day 4 embryoids induced from Pre-ME(12h) or 23 
Comp-hPSC by BMP containing cytokines. Scale bar: 50 µm. 24 
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h. Comparison of sensitivity of 2 NANOS3 reporter cell lines. FACS patterns of 1 
day 4 embryoids induced from Comp-hPSC (harboring NANOS3-mCherry 2 
reporter or NANOS3-tdTomato reporter) with or without Cytokines. 3 
i. Comparison of hPGC induction efficiency derived from Pre-ME(12h) or 4 
Comp-hPSC. Representative images and FACS patterns are shown. 5 
j. Scatter plot shows % NT/AP +ve cells in indicated condition (n=6). Paired 6 
T-test was used to test for statistical significance (* p<0.05) 7 
 8 
 9 
Extended Data Fig.5 Characterization of Pre-ME and ME induced from 10 
Conv-hPSC 11 
a. Immunostaining of Conv-hPSCs during 12–24h ME induction. Scale bar: 50 12 
μm. 13 
b. Gene expression (RT-qPCR) change during ME induction. 14 
c. FACS patterns of day 4 embryoids induced from Pre-ME(12h) with cytokines. 15 
Pre-ME was induced with or without GSK3i or Activin A. 16 
d. FACS patterns of day 4 embryoids induced from Pre-ME(12h) with cytokines. 17 
Pre-ME was induced with or without BMP2 or the inhibitor. 18 
e. Schematics of DE or lateral mesoderm (LM) differentiation from ME 19 
f. FACS patterns of day 2 DE (% CXCR4 +ve) and day 1 LM (% PDGFRa +ve)  20 
induced from 24h of ME induction. 21 
g. Relative induction efficiency of DE or LM from ME induced with or without 22 
BMP2 (DE: n=5, LM: n=6). Paired T-test was used to test for statistical 23 
significance (* p<0.05) 24 
h. Immunostaining of DE and LM in Extended Data Fig.5f. Scale bar: 50 µm. 25 
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i. Schematic of spatial-temporal progression from Conv-hPSC to ME and the 1 
signaling. 2 
 3 
 4 
Extended Data Fig.6 Robust induction of cynomolgus monkey PGC 5 
(cmPGC) from cells during ME differentiation 6 
a. Schematics of in vitro differentiation of cmPSC. The same system was 7 
adopted as shown for Conv-hPSC differentiation in Fig.3.  8 
b. Bright field Image of undifferentiated cmPSC. 9 
c. Immunostaining of day 2 embryoids induced with Cytokines from cells at 0h 10 
(=cmPSC), 12h and 24h during ME differentiation. Dashed lines highlight 11 
SOX17/BLIMP1/TFAP2C +ve cmPGCs. Scale bar: 50 µm. 12 
d. Immunostaining of day 2 Pre-ME(12h)-derived embryoids in Extended Data 13 
Fig. 6c for pluripotency markers. Notably, cmPGCs express SOX17 but not 14 
SOX2. In contrast, cmPSC colonies express SOX2 but not SOX17. 15 
e. Immunostaining of day 2 cmDE induced from Pre-ME(12h) and ME(24h). 16 
Scale bar: 50 µm. 17 
f. Immunostaining of day1 cmLM induced from ME(24h). ME were induced with 18 
or without BMP. Notably, adding BMP during ME differentiation increased the 19 
efficiency for FOXF1/HAND1 +ve LM cells, as shown in Conv-hPSC (Extended 20 
Data Fig. 5e-i) 21 
Scale bar: 50 µm. 22 
 23 
 24 
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Extended Data Fig.7  Chronology of transcription factors expression 1 
during hPGC induction  2 
a. Schematic of hPGC induction from Pre-ME(12h). 3 
b. Images of day 2 and 4 embryoids in response to BMP2 alone or BMP2 with 4 
LIF, SCF and EGF(=Cytokines). Notably, BMP2 alone can induce hPGC at 5 
almost the same efficiency as the full cytokines, but do not survive during 6 
extended culture, as shown previously.  7 
c. Immunostaining of embryoids induced with BMP2 alone or BMP2 with LIF, 8 
SCF and EGF showing expression of SOX17, BLIMP1 and TFAP2C. Scale bar: 9 
50 µm. 10 
d. Proportion of SOX17 +ve cells indicated in Extended Data Fig.7c. 11 
e. Immunostaining of embryoids induced with BMP2 alone or BMP2 with LIF, 12 
SCF and EGF showing expression of SOX17, BLIMP1 and NANOG. Scale bar: 13 
50 µm. 14 
f. Proportion of SOX17+ve cells in Extended Data Fig.7e. 15 
 16 
 17 
Extended Data Fig.8 Effect of NANOG on hPGC induction, characterization 18 
of NANOS3-tdTomato reporter hPSC containing inducible SOX17, BLIMP1 19 
with or without TFAP2C, and similarity between Cytokine- and 20 
SOX17/BLIMP1-induced hPGC 21 
a. Represents overexpression of Dex-inducible NANOG transgenes in NT 22 
reporter Comp-hPSC. 23 
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b. Day4 embryoids following induction of NANOG (by Dex), with or without 1 
cytokines as indicated. 2 
c. FACS patterns after induction of hPGCs; NT/AP +ve cells (%) shown in 3 
Extended Data Fig. 8b. 4 
d. Represents overexpression of Dex-inducible SOX17, Dox-inducible BLIMP1, 5 
Shield1(S1)-inducible TFAP2C transgenes in NT reporter Comp-hPSC. 6 
e. Immunostaining of NT reporter Comp-hPSC +iSBT 1 day after induction of 7 
SOX17, BLIMP1 and TFAP2C by addition of Dex, Dox or S1. Scale bar: 50 µm. 8 
f. Immunostaining of NT reporter Comp-hPSC +iSB 1 day after induction of 9 
SOX17 or BLIMP1 by addition of Dex or Dox. Scale bar: 50 µm. 10 
g. Immunostaining of day 2 embyroid induced with or without Dex to induce 11 
nuclear localization of SOX17. Notably, accumulation of SOX17 signal is 12 
observed in +Dex condition. 13 
h. Changes in gene expression (RT-qPCR) during hPGC induction: 14 
Comp-hPSCs control (AP +ve cells); NT +ve hPGCs induced by SOX17/BLIMP1 15 
or Cytokines; NT -ve cells in cells exposed to Cytokines. 16 
i. Unsupervised hierarchical clustering (UHC) of gene expression. 17 
j. Gene set enrichment analysis (GSEA) of 123 hPGC-specific genes 18 
(Supplementary Table 1) on the transcriptome of cytokine- and 19 
SOX17/BLIMP1-induced hPGCs. 20 
k. Heat map showing expression of epigenetic modifiers related to global DNA 21 
demethylation. Same datasets as shown in Fig. 4e were used for analysis. 22 
 23 
 24 
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Extended Data Fig.9 Response of SOX17 KO Comp-hPSC to SOX17 1 
a. Overexpression of Dex-inducible SOX17 (iS) in SOX17 KO Comp-hPSC. 2 
b. Gene expression (RT-qPCR) on day 4 of FACS-sorted NANOS3-mCherry 3 
(NC)/Alkaline phosphatase (AP) +ve hPGCs by RT-qPCR. 4 
c. FACS analysis of d2 embryoids induced from WT Comp-hPSC, SOX17 KO 5 
Comp-hPSC and SOX17KO Comp-hPSC rescued with SOX17GR transgene 6 
(iS) (% CXCR4/AP+ cells). 7 
d. FACS pattern of day 2 embyoid induced from NT reporter Comp-hPSC 8 
showing AP/CXCR4 +ve cells expressing NT. 9 
e. Represents SOX17 inducible system (iSdd). Expression of SOX17 fused with 10 
destabilized domain (DD) can be induced by Doxycycline (Dox); addition of 11 
Shield1 (S1) can stabilize SOX17-DD protein. 12 
f. Western blots showing SOX17 expression level in day 5 embryoids from 13 
SOX17KO+iSdd Comp-hPSC. Embryoids were induced with Cytokines. To 14 
induce SOX17, different concentration of Dox and S1 were added. As controls, 15 
NC/AP +ve hPGCs and NC/AP -ve cells from WT Comp-hPSC-derived 16 
embryoids induced with Cytokines were used. Histone H3 (H3) was used for 17 
internal control. 18 
g. Immunostaining of day 4 embryoids from SOX17KO+iSdd Comp-hPSC. 19 
Embryoids from SOX17 KO and WT Comp-hPSC induced with Cytokines were 20 
used as controls. Scale bar: 50 μm. 21 
h. Quantification of immunostaining data in Extended Data Fig. 9g. The 22 
numbers of OCT4/BLIMP1 +ve hPGCs, FOXA2 +ve endodermal cells and 23 
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OCT4/BLIMP1 +ve hPGCs expressing FOXA2 were counted from 3 different 1 
embryoids. The proportions of the 3 populations are shown. 2 
i. Expression of SOX17 and BLIMP1 (RT-qPCR) in d4 embyoids in response to 3 
different SOX17 dosage. 4 
 5 
 6 
Extended Data Fig.10 Response of SOX17 KO Comp-hPSC to SOX17 and 7 
BLIMP1, and changes in epigenetic modifier expression after 8 
overexpression of SOX17/BLIMP1 9 
a. Overexpression of Dex-inducible SOX17 (iS) and Dox-inducible BLIMP1 (iB) 10 
in SOX17 KO Comp-hPSC. 11 
b. Immunostaining of Comp-hPSC 1 day after induction of SOX17 (Dex) or 12 
BLIMP1 (Dox), or both, and d2 embryoids following Dex-induced SOX17 with 13 
endogenous or Dox-induced BLIMP1. Scale bar: 50 μm. 14 
c. Gene expression (RT-qPCR) in day 4 embryoids following induction by Dex 15 
(+SOX17), Dox (+BLIMP1), or Dex+Dox (+SOX17/BLIMP1). Bulk cells of 16 
embryoids induced from SOX17 KO and WT Comp-hPSC with Cytokines were 17 
used as controls. 18 
d. Upon specification, hPGCs become refractory to Activin or Wnt signaling. Left 19 
schematic shows the experimental design. The embryoids were transferred to 20 
the medium with or without GSK3i (3M) or ActivinA (100ng/ml) at day 0, 1 or 2 21 
to see the effect on PGC induction. FACS patterns (right) show the induction 22 
efficiency of hPGC (%; NT/AP +ve) at day 4. 23 
e. Day4 embryoids induced by cytokines with or without ActivinA or GSK3i. 24 














gene.symbol Comp-hPSC(SB)#1Comp-hPSC(SB)#2Comp-hPSC(WT)#1Comp-hPSC(WT)#2 d1_hPGC+SB#1 d1_hPGC+SB#2 d2_hPGC+SB#1 d2_hPGC+SB#2 d4_hPGC+Cy#1 d4_hPGC+Cy#2 hPGC_wk7_M#1 hPGC_wk7_M#2 Soma_wk7_M#1 Soma_wk7_M#2
APOE 8.596018998 8.861014098 8.426161467 8.587979933 9.654842323 9.547795604 9.818609396 10.19795914 9.470248321 9.581202929 11.08634287 10.81188784 6.054554613 5.963872316
MKRN1 8.384838643 8.356207256 8.57620232 8.444875456 9.172017229 9.496313791 9.496349691 9.615043241 10.43865687 10.62234087 11.06229777 11.72127587 7.9188998 7.660901354
PDPN 8.031643387 8.038782256 7.533708895 7.576321854 10.57081358 10.82341212 10.94030994 11.15614319 11.17572058 11.23647838 10.59303579 10.65195556 5.972540029 6.023869642
TCL1A -0.350360289 -0.352897479 0.369251498 -0.334552612 -0.316657072 -0.29166848 0.767972025 -0.228285591 5.232721673 5.341067035 10.49579933 10.17962593 1.90375308 1.346194352
EPB41L2 9.062313803 9.241597472 9.071371878 9.069468612 8.639237415 8.457985297 8.552916505 8.729429332 10.82507664 10.85919293 10.19019862 9.719463991 6.534071694 7.071475911
PCSK1N 1.644463189 2.056963498 -0.220887524 1.660270866 7.369328311 7.072388808 8.265295844 8.415195064 8.041989498 8.083124443 10.14323371 8.286740229 4.739878812 2.077983425
MYBL2 8.677424622 8.657203513 8.796242211 8.797739259 9.213197332 9.431477226 9.623266492 9.385925744 10.23209702 10.30007285 9.976901413 9.974230781 6.121984397 5.51746219
SCGB3A2 12.34683261 12.57735976 12.58863099 12.63737107 9.609751952 9.692153786 9.524456047 9.295364263 10.04733383 10.43367747 9.933304172 9.037893115 5.483359339 6.811629592
LMO2 3.575531269 3.388569507 3.236249367 3.647922474 4.772733218 5.077829729 5.425046824 5.577311733 4.587513383 5.849170482 9.933049425 9.549070053 4.335535567 5.167388531
RASD1 4.967218281 4.490749902 4.435291301 4.587097281 9.579860211 10.22125769 10.16108323 10.49187874 9.647446028 10.38111163 9.922371862 9.886974854 6.093175298 6.149199749
PIM2 8.336571749 8.498457584 8.387027323 8.384957795 10.3083627 10.53853232 10.08846233 10.09750457 10.56140157 10.83280613 9.892592391 8.984123407 5.319626541 4.839472317
STOM 7.287550506 6.836028484 6.973214961 6.798339316 8.902857212 9.369538935 9.509439011 9.364470743 10.22771598 10.42905461 9.853503657 9.378526745 6.389660781 5.178426802
AKAP12 8.339032348 8.219382613 8.503370115 8.361171432 10.26311107 10.59072972 10.48139107 10.75519494 10.25612929 10.47336812 9.682010116 10.11055416 6.757097615 6.527017002
ETV5 6.003731483 6.273180299 5.843876935 6.178112186 7.974732202 7.870633144 7.759921246 7.822095583 8.743721075 8.814118337 9.422132232 9.603716543 6.149086536 5.341985639
SAMHD1 4.472290737 4.361693801 4.51085292 4.45804118 6.657625172 6.748053327 7.096618718 7.12373561 8.387012507 8.741580671 9.20736815 8.756121002 5.897980733 5.505570475
LCP1 6.059960073 6.144885724 7.436830754 7.798233774 5.1292872 5.256155405 6.514575774 6.269497612 8.35592871 8.467594431 9.17754222 8.656140698 4.440605847 4.171552213
CDCA7 7.8753624 7.758405299 7.431644676 7.557026932 6.209683206 6.57027483 6.93761879 6.53800548 8.766151375 9.065195694 9.145597969 8.914279989 5.732656127 5.965644034
NANOG 10.4631086 10.54675118 10.65125999 10.59386163 9.736796919 10.20292676 10.7168642 10.68581755 11.86052021 11.96854973 9.14468277 9.876426476 5.300233325 4.862514367
KIT 5.256839669 5.426881934 4.585130026 5.076582207 6.790696999 6.942390064 7.598133627 7.676730006 7.754724533 7.583580689 9.136378156 9.187542845 3.098569992 2.845865846
NLRP9 1.498674155 -1.673788037 0.370289035 0.34455683 1.532377372 0.709369057 1.032043968 0.450823852 1.754289838 1.913261273 9.077297978 9.077576788 -1.417137478 2.112766635
TRIML2 5.667048587 5.52510834 7.14435741 6.624753309 1.037786792 1.062775383 5.122415888 5.155905616 8.508356695 9.020869899 8.97312111 8.723646615 -0.326765558 -0.884324285
NANOS3 0.497221812 0.494684621 1.216833599 0.513029489 6.174781219 5.310801123 4.522444721 4.706759351 5.745884734 5.381294214 8.951323278 9.066214426 0.75133518 1.193776453
FAM162B 2.669481649 3.541413577 3.389093437 3.100326826 5.577653985 5.001191953 5.846707652 6.039483861 6.616975037 7.225979394 8.902399995 9.045999646 0.338632517 -0.21892621
ASRGL1 7.631795723 7.779153963 7.877866292 7.787976056 8.796285547 9.420062795 9.101932415 9.291254165 9.511530039 9.446663005 8.850905893 8.616374473 4.269003698 4.230318281
HENMT1 4.583365149 3.223275955 4.337742355 2.826583322 3.95995608 4.039392456 4.202126454 4.347887843 4.678834566 4.782310889 8.819890621 8.96353697 4.801854608 5.009830627
UPP1 6.060587233 5.961542061 7.171707984 7.150819751 6.12784301 6.802645246 7.257368644 6.948196677 7.160932109 7.062745705 8.75415388 8.516837597 1.712664587 2.807182556
CACNA2D2 6.094449489 5.873732129 4.736058764 5.118669406 9.895795116 10.1867575 10.39111904 10.18102551 10.1563767 10.23353665 8.740845784 8.665764021 5.534336688 5.321518847
ESRP1 8.788137918 8.888988559 9.042199048 8.99469239 10.44456206 10.62087597 10.0930558 10.08466232 9.412076265 9.904729802 8.722248737 8.706283593 2.600729866 2.498850623
COL4A3BP 6.553955734 6.506094553 6.630176042 6.464906097 9.285579478 9.330599499 9.18455404 9.28313191 9.539299693 9.509833259 8.694579197 8.664763615 5.230524073 5.562289115
PQLC3 4.987368024 4.780472335 5.336611361 4.734686865 5.521969477 6.004639906 6.877625771 6.816150496 8.913806945 8.942801593 8.6860683 8.511426057 3.798963157 4.00039633
ERVW-1 4.70352913 4.528810965 4.671068431 4.351605023 7.369500563 6.932145941 7.268117674 7.422538971 6.920483193 7.0858524 8.674597201 8.567420649 4.612994327 5.561971454
ETV4 6.475193496 6.816388771 7.007381691 7.083268474 7.939412944 7.782198205 7.629685473 7.706535406 8.35138185 8.362922921 8.590549944 8.969622085 3.499572468 3.407677312
SOX15 5.668899383 5.198583231 5.723695362 5.247301747 7.719153776 7.473407704 7.888985196 7.426817751 7.643095564 7.797390513 8.554610225 8.400091943 3.601084656 3.249976806
DNMBP 6.03897138 6.407222435 7.577021589 7.338373328 6.899500804 6.734828177 6.64643449 6.663328242 7.164666468 7.217262894 8.547819683 8.469291241 5.358343388 5.321724235
TFCP2L1 2.912103789 2.464155451 3.538606172 3.015374308 8.011223141 8.510923637 7.571532719 7.935045296 7.42999505 7.525796935 8.532496263 8.657371655 0.253679999 0.068090049
CPEB1 3.163768454 2.161231263 3.919004151 3.665002958 5.852823499 5.998564251 6.893863328 6.909358893 5.976332261 6.507272474 8.476113711 8.545730589 0.555385346 3.1233575
GABRA3 0.237457236 1.55684814 0.542031524 1.060619835 5.369192536 5.843043505 7.389212551 7.376340222 8.46936164 8.686631716 8.447454025 8.310423509 3.106280448 2.634451595
TCL1B 4.042954752 3.983834033 2.762566539 2.817754329 3.546143252 3.860638461 4.746249566 4.822141737 7.403006355 7.248955249 8.335482586 8.30943967 -1.403371598 0.624032175
SMAGP 5.162345658 4.319286682 5.754722257 5.101191353 2.629702053 3.124175928 3.920782027 4.105096657 8.974909466 8.91148848 8.282805609 8.368336416 3.9310322 3.177076259
BEND4 5.218997636 5.100983228 5.332993251 4.911670447 4.742944697 4.930204717 5.466475101 5.810557618 8.166663337 8.555466251 8.279597687 8.428005703 0.641426753 0.939478116
SLC43A1 5.926639489 5.246030394 6.470679712 6.156226457 6.266151136 6.452030917 6.817561307 6.620256172 8.436011764 8.806949972 8.229745683 8.200501627 2.258755369 2.701196642
FAM46B 6.512668677 6.546110784 6.515813181 6.088944293 6.97229771 7.086662109 7.536919748 7.243791495 7.450763367 7.730280465 8.126768762 8.059763488 1.837865144 2.486757294
TFAP2C 7.061462623 6.897733168 7.603658897 7.18064804 8.734067148 8.952031673 9.162169266 8.87059801 9.556939599 9.552992163 8.101967269 8.336785402 -1.135635121 0.306806152
PLBD1 7.271591457 7.339041785 7.206345926 7.088715139 7.096895525 7.776616896 8.389923771 8.524635549 9.729221877 9.746940134 8.052407725 8.140960587 4.662441162 4.278214037
NFE2L3 7.650413967 7.509521855 7.291313779 7.321776113 7.17984253 7.650478047 7.416172869 7.38415549 8.88550592 9.002789019 8.022390481 8.105072926 4.775510278 4.642266863
OSBPL3 5.592824352 5.500401658 5.498409082 5.265980455 4.907204936 5.213707354 6.305769337 5.685555089 7.377206256 7.485344177 8.003116186 8.049563649 1.797694202 2.19949349
GPHA2 0.554328015 1.551790825 1.273939802 1.570135692 4.909959327 5.367907326 4.672660329 4.261365214 3.9798687 4.345291013 7.980948745 8.09804122 3.130369478 4.250882656
DDIT4L 3.139013154 2.44459826 2.714235032 2.84996625 6.334987801 6.519633058 5.920310481 5.423359282 4.979591338 5.057032888 7.971127611 8.493942331 4.322737195 4.301231368
CABYR 5.558959528 5.185328186 5.053697905 4.929050673 6.720670358 6.936601732 6.631967852 6.994010721 7.80568117 7.27357164 7.933155211 7.898542834 3.857016244 4.270311171
PHLDA3 5.816954472 4.970068153 5.341309968 4.921298824 6.301764444 6.286111051 6.107239469 6.235161265 7.643416154 7.806637062 7.865793873 8.05688693 2.767287093 3.017083287
SCUBE2 0.712787098 -0.512142513 0.794968965 -0.493797646 4.187062907 4.455977081 4.290551031 4.656863495 7.429814764 7.673675097 7.846903494 5.738651999 -0.840454455 -0.398013183
KIAA0226 4.689626299 4.029976822 4.590844893 4.048321689 4.421059947 4.866499534 5.615313535 5.859290456 5.791884881 6.221771246 7.82511545 7.919739955 4.320897283 4.496234486
KLF4 4.095650814 3.919084224 4.622617523 4.484916886 6.291974232 7.108538933 7.316793934 7.350750931 7.553612976 7.869019752 7.808656437 7.942893203 3.977795405 4.215416886
GCNT1 5.635735718 5.64376777 5.457709223 5.488893058 7.348505003 7.398127575 7.669420207 7.589210813 8.299897286 8.170437539 7.725665001 7.304979806 3.622565208 4.175564856
SUSD2 2.579940161 3.180067474 2.245104165 2.010785338 6.878346605 6.973856888 7.433232934 7.282517712 7.454035472 6.954677768 7.705039007 7.931702059 -0.11347905 0.5216073
EFEMP1 3.892113463 3.853952363 3.061528167 3.009800754 3.568264675 3.878655486 5.267603616 5.211225008 6.855852181 7.216295386 7.69703759 7.506909766 2.646655822 -0.768883901
CRIP1 2.285480189 1.282942999 1.683163882 3.564322272 7.074070909 7.093706266 6.850068733 7.102435081 6.063692493 5.997371616 7.694234499 6.691689871 1.918105181 2.119538354
PROM1 6.690020092 6.319864899 5.454774035 5.239324101 7.682577326 8.191695941 7.890618587 7.683032217 7.911591534 8.28937905 7.666243489 7.709779358 3.198913765 4.7106177
FAM102B 4.674949152 4.953824897 4.826149615 4.712783135 6.60713361 7.16248426 7.519106503 7.262496071 8.112391926 8.05563467 7.583007426 7.239363266 4.258370146 4.058794228
PCP4L1 1.940783671 1.616318386 2.660395459 3.722126095 5.992408797 5.608284723 7.402523808 8.06285837 10.42477407 10.97815476 7.530903134 4.577606281 2.457931446 3.637338312
FRMD6 4.384891828 4.481890311 4.408657008 4.740185971 5.196202624 5.549972981 6.038261417 6.077132025 8.172121557 8.329329306 7.478215649 6.939567139 3.500028783 2.554199466
UTF1 1.50283178 1.50029459 2.222443567 2.741031878 6.580929117 6.796740051 6.14472605 6.017223901 5.890897759 6.176981113 7.430646653 7.919688706 2.756945148 3.199386421
PRDM1 9.147785589 9.243527917 7.126300299 7.870434785 15.35813953 15.26775567 15.39924718 15.80060459 9.261997333 9.610528746 7.370497323 8.619761911 1.183268455 -2.544215274
CLEC4D 1.177161283 0.174624093 0.896773071 2.652400579 5.514645249 6.130670856 5.361582788 4.106590904 6.509592564 5.980096923 7.309334655 6.819438323 -1.568725348 -0.126284076
TLDC2 2.772395405 2.769858215 2.598922397 2.409691459 4.059855215 4.774503686 4.47569022 5.148226696 6.336215465 6.277956184 7.289989796 7.2577753 3.647997151 3.897793345
ITGB3 2.1329937 3.339909876 2.710586483 2.956156299 5.634302468 5.634629005 6.622013421 6.698011894 5.703584718 6.260240086 7.220241201 6.620997473 3.635034582 3.151476436
IL4R 4.496338018 4.585723317 4.611878482 4.787780137 4.968614249 4.950958503 4.890304775 4.728037208 6.445186685 6.472332909 7.164416075 6.502617093 1.202963591 1.114890147
STON2 6.029064489 5.679114232 5.679689666 5.800798849 5.896346945 6.185419557 6.749102567 6.625294902 8.111580537 7.549564035 7.15220671 7.443608079 3.599481403 3.697274504
RBM24 3.015265249 2.860724965 2.412948941 3.796607672 6.048968466 5.9119003 6.319464108 6.990337535 6.451861122 7.04093393 7.131013073 6.689842781 1.406882141 -1.610108205
ATP2A3 2.869657254 2.189048159 2.911197136 2.972927772 7.676499678 7.305559594 6.968129146 7.471512217 5.446507262 4.953402001 6.921368598 7.281865676 2.796195965 0.88813999
PSORS1C2 1.926639489 0.924102299 1.231213777 1.942447166 3.282270801 3.685771016 4.292899316 4.44103161 5.739203297 5.764908201 6.915854907 6.030820633 -0.819247143 -0.37680587
CAPN13 4.03626398 3.756192814 3.681875186 3.315106063 5.475959557 5.849843291 6.002593201 6.228728006 7.94326259 7.778317377 6.880140035 7.755396943 -2.031550746 0.732818621
SOX17 6.274293032 7.031142731 4.885651929 7.023585735 6.681149668 6.489326871 7.298356685 7.672379991 9.179902339 9.494132437 6.85809537 7.620965108 -0.84663303 -1.404191758
PIFO 4.953047322 5.029222108 5.390623742 5.060278027 4.959529071 5.555674364 5.633693398 6.081847884 7.593106166 7.485821694 6.755384605 6.032827517 1.166133423 2.15606249
KLRG2 4.665939675 4.482830239 4.468013622 3.709761728 3.550779506 3.51163776 3.433774742 4.639150987 5.816647382 6.393286573 6.728684128 6.72804988 0.832590202 -0.309931026
NLRP7 5.552387604 6.062663129 5.827336723 6.23301109 6.437992183 6.749382436 7.037681767 7.075133513 6.972504617 7.384969691 6.648937066 7.378318864 -0.966088531 -0.523647258
GABRQ 4.188161763 3.543518165 3.613590446 3.494748837 8.257318066 8.629131323 8.6698421 8.843509486 4.968229189 5.160520698 6.588908737 6.081353739 1.925699606 1.721777833
TDRD12 1.967425104 1.479461086 2.201610064 1.34580286 2.28123624 2.026116913 2.185293091 2.530072394 2.344602767 3.131605425 6.581131386 8.063111454 -0.263888355 0.663979745
GNA14 3.140261701 3.400758916 3.345300315 3.293572901 3.173964918 3.78391601 5.52162842 5.3833518 7.831146952 7.899622701 6.580138527 6.596876336 2.159909815 3.559282366
AFAP1L1 2.069872373 1.526766801 0.959409161 1.407608145 3.74743178 3.486116186 4.021094701 4.300471528 3.74916965 4.311496779 6.577413098 6.087516766 1.967841931 1.466866732
PPARG 1.91876176 1.693832148 0.415981126 1.127214515 4.099306366 3.924986149 4.515141371 3.933921255 2.536947523 3.63933543 6.538027568 7.042571711 1.824951825 1.39292398
FGFR3 5.117300552 4.768767507 5.743802935 5.545491275 8.64191362 8.703239364 7.593184871 7.810123892 7.39699037 7.66377954 6.46751363 7.858579428 0.743382698 1.185823971
DND1 5.469156636 5.531714474 5.356225169 5.077306344 5.387382636 5.149336822 5.237546479 6.153826022 8.099667752 7.639200255 6.450954582 7.664926157 4.16033381 3.843783182
C1orf115 2.879129332 2.522955187 2.660141664 2.619302566 4.656057134 4.699661404 4.721827203 5.259001788 7.796630333 7.616850308 6.418031776 6.258608648 1.194643245 2.959012613
RIPK4 4.05361696 4.764198622 5.9085806 6.496239304 4.857022558 5.001750394 4.598763941 4.374237338 6.956505046 7.322101587 6.385113535 4.919879257 1.624920504 1.819434263
DEPDC7 2.583031328 3.513379942 3.165139592 3.139407387 4.649156023 4.76725402 4.885788214 5.078564422 5.967641749 6.116196569 6.360742641 5.9804708 0.962675579 1.142082446
ADAMTSL3 1.344143218 0.954582905 1.146217166 1.664805477 2.244579905 2.222262782 3.767330114 2.626682589 6.503381784 6.204147861 6.315569323 6.646770394 -0.319281253 0.275163113
FAM124B 1.337215616 1.334678426 1.931296521 1.353023293 6.160995764 5.538865379 6.870585429 7.209718169 6.596295155 6.054178032 6.254538115 7.515232641 -1.993633516 -1.551192244
RTN4RL1 0.59050542 1.073395057 0.795544034 1.284385002 4.346674662 3.819122231 4.596363005 4.273295073 6.49750403 6.451857746 6.242685851 5.549256125 -0.892346806 1.424563585
COL23A1 2.847420472 3.166811377 1.704535783 2.863228149 5.478058832 5.733931306 6.444724591 6.327047175 7.687304886 7.711060975 6.168150034 6.260027925 -0.220394254 0.222047018
FMN2 0.251442911 1.248905721 0.864139495 2.414091976 3.178230925 3.2576673 3.262860021 3.632251878 5.431283801 5.042405909 6.081960583 6.065803707 1.907654723 0.310567632
FAM155B 3.877047396 3.64318466 3.1271739 2.59739919 3.285146129 4.063494753 3.525894427 3.529636812 5.498312552 6.093695138 6.034207452 6.047743735 0.698201358 -2.181285465
MYB 2.503423574 3.867668714 2.975107848 3.593231832 6.508367798 6.925212667 6.928417226 6.881396497 5.631648718 6.116848386 5.839658068 6.612796142 2.264496931 2.952050702
BSPRY 3.151503337 1.901038633 3.832640977 3.241311595 3.39671066 1.962267633 4.606870638 4.417967945 4.818501349 4.810016039 5.750772237 6.260875905 -0.257348307 0.185092965
NGEF -1.552309774 0.030115536 0.489230108 -0.536502097 4.61067646 4.029943991 5.041755971 4.719512044 3.927678695 3.331762628 5.672122105 5.969377125 -0.298196406 -0.270792632
ADCY1 2.959602773 2.631079271 2.695334225 2.87471645 4.844002046 4.809347692 3.933118534 4.536681378 7.494372527 7.192104954 5.588561977 5.186128487 0.985910224 1.961783696
MMP25 3.429666544 3.297846337 2.827350236 3.486116205 5.673936747 5.277938573 4.844980596 5.163925212 5.002764417 5.067098979 5.550126495 5.761634572 1.724421897 1.581900669
CD38 -1.375039922 0.622422888 -0.33350004 0.225730256 -0.341336705 0.683651887 3.100844397 3.139352199 7.008272527 7.62407613 5.44706551 6.297539878 0.464035947 0.643442814
ADTRP 0.0887314 1.893549132 1.393305688 2.804978795 1.444362712 1.73238571 3.73062567 3.911245817 5.608248233 5.399068557 5.325874331 5.957284296 2.43030761 -1.214713959
KANK4 0.906980963 0.904443773 -0.051479155 0.507751141 1.400115799 1.965672772 3.669169467 3.198980663 6.568719869 6.416762208 5.144123894 5.615753415 2.019075327 -0.074536301
C12orf39 -0.753159349 2.244303461 -0.033547562 1.584576423 4.565946087 4.392995302 3.613100479 4.275805945 2.431373236 3.037803649 5.142946665 4.553514659 0.08591652 0.528357793
KIF5A 2.912881565 3.343303782 2.834127213 3.38812086 5.470146738 5.397838128 5.185019215 5.552231956 4.862948896 5.126077563 5.061295577 5.394053304 1.889460958 -1.712491889
S100Z 3.03626398 3.381650093 3.820006105 4.293079757 3.310975297 3.722987012 3.695164675 3.399346778 5.945789518 5.415101074 4.981085279 4.445385257 -1.16905427 -0.726612997
FILIP1 1.806144197 2.017731812 2.663259508 2.307378701 3.703785864 4.663923312 4.655659752 4.078778572 3.209317068 3.196107529 4.96742036 6.107311729 2.438769188 1.106770161
HS3ST4 1.447239454 3.398898574 2.488779336 0.463047131 0.480942671 -1.494068737 2.266011486 2.739239154 4.695902377 4.331311856 4.917581562 3.683524134 -2.298647177 -1.856205905
ACE -1.146559722 -0.564134411 -0.841985434 0.19117605 3.72003351 3.371563706 3.463625688 3.9527949 4.385896167 4.213246111 4.857606037 5.555699423 -2.892446353 -0.450005081
BCL6B 3.15755059 3.203923 -1.980818618 0.637305367 5.493144149 4.643663623 4.002864409 2.743572388 4.532465201 4.753497605 4.853569631 5.580248394 1.254122681 1.318052331
TAC3 2.152554977 2.998014693 1.550238669 1.846434559 4.256647522 3.589758409 5.341276619 5.122626582 8.320599439 8.292128112 4.32234264 5.722263391 1.406668345 1.112144024
TSPAN15 3.616666398 2.688129789 2.673313172 2.84397818 3.209797024 3.127870412 2.29442612 1.812741678 3.678802352 3.574739381 4.296553758 4.531022983 -0.377147747 1.065293525
STARD8 3.017702385 2.652595115 3.152351672 2.721566056 3.239032606 3.365900811 3.77346462 3.697772537 5.08067299 5.071699789 4.29642442 4.901685321 0.271815754 1.003763643
CLDN7 6.344527157 6.833170321 6.799085371 7.076980443 7.063849088 6.759047467 7.097404 6.943355139 7.148161526 7.287896743 4.112470693 4.053208716 0.023731689 -1.118789539
UMODL1 0.475522761 0.665630649 1.387779626 0.268938017 3.509225978 3.2814485 3.644481148 3.434098727 4.051480288 3.856020989 3.955063806 4.415414439 -1.492756292 -2.63527752
SSUH2 0.031751324 0.766179728 0.751363111 -0.5374035 2.387382636 1.827408727 3.088683093 2.26930324 5.301172807 4.945571069 3.709022735 2.820577027 -0.714135308 -0.271694035
DDX53 1.628703362 2.041203671 2.670243244 2.22947354 2.536875698 4.189895512 4.162073176 3.335740561 4.699579166 3.927813264 3.61791878 4.20602496 -1.70214577 -1.259704497
PKIB 6.237949909 6.246908358 6.606487256 6.447844638 6.732133597 6.342084689 5.540245058 5.584064882 5.245194105 5.086975364 3.583309137 5.873022737 0.111241494 -1.031279734
ANKDD1B 0.77243884 1.577256572 2.192490345 2.595601439 3.850536176 4.713773698 5.040518273 4.286830961 4.74546732 4.115942861 3.346616758 5.45497975 1.026552208 1.053955982
KIAA0319 -1.07042522 -1.07296241 -1.350813433 -1.054617543 0.700243591 1.49076693 1.163384311 1.990248934 0.770152964 0.813647182 3.175129951 4.153786628 0.768650649 0.500598539
LAD1 1.176663029 3.048594957 2.311312316 2.307947924 2.947331841 3.235354838 4.437953297 5.10609265 5.996281595 5.77039368 3.083416287 3.593519955 -1.154186103 0.28825517
EVX1 2.594892333 1.855389549 2.214968447 4.025737509 -1.278295045 -1.253306454 -1.193665949 -1.189923564 5.896918481 5.20143076 2.677217155 4.556554633 -2.057884894 -1.615443622
ADAMTS8 0.125401502 0.444792407 0.166941384 -1.858790821 -1.84089528 -1.815906689 -0.171303683 0.247476201 5.135904688 4.854963955 2.617117261 4.449149024 -2.620485129 0.143884238
LOXHD1 1.680459189 2.262884499 1.5375745 0.833770389 3.147121813 3.172110405 4.564326249 3.434802103 5.720256681 5.106789641 2.347746512 2.402170696 -0.387355538 -1.359951764
PTPRT -1.957621457 -3.545121148 -3.82297217 -1.204848186 3.524542261 2.908425274 3.067601453 3.910407619 1.574834432 1.926450945 1.81586527 2.459235469 -0.82903897 -1.524101222
AWAT2 -0.955577497 -0.958114687 -0.235965709 -0.93976982 1.885480643 1.688076813 1.747717318 2.973852124 4.602413484 4.972889025 -0.551324579 3.602635279 -1.701464128 -1.259022855
Supplementary Table 1
Supplementary Table 2
Antigen Company Cat No. Dilution
NANOG Peprotech 500-P236 1:300
BRACHYURY(T) R&D AF2085 1:300
OCT4 SantaCruz sc-8628 1:300
OCT4 BD Biosciences 611203 1:250
TFAP2C SantaCruz sc-8977 1:300
TFAP2C R&D AF5059 1:500
SOX2 SantaCruz sc-17320 1:300
SOX2 Abcam ab97959 1:200
SOX17 R&D AF1924 1:300
BLIMP1 eBioscience 14-5963 1:50
Sda/GM2(CT1) in house (Klisch et al ., Reproduction  (2011)) 1:50
Phospho-Smad1/Smad5/Smad8 EMD Millipore AB3848 1:300
FOXA2 Cell Signaling Technology 8186P 1:300
HA-tag Cell Signaling Technology 3724S 1:500
HA-tag Biolegend 901501 1:500
Myc-tag Cell Signaling Technology 2276S 1:4000
5mC Eurogentec BI-MECY-0100 1:500
5hmC Active Motif  39791 1:1500
G9a Cell Signaling #3306 1:100
H3K9me2 Active Motif 39376 1:1500
Tet1 GeneTex GTX627420 1:200
UHRF1 Active Motif 61341 1:300
DNMT3A Santa Cruz sc-20703 1:500
RFP (for tdTomato) chromotek 5f8-100 1:500
HAND1 R&D AF3168 1:250
FOXF1 Abcam ab168383 1:250
Gene Forward (5'→3') Reverse (5'→3')
GAPDH CGCTTCGCTCTCTGCTCCTCCTGT GGTGACCAGGCGCCCAATACGA
OCT3/4 GCTGGAGCAAAACCCGGAGG TCGGCCTGTGTATATCCCAGGGTG
NANOG TGCTGAGATGCCTCACACGGA TGACCGGGACCTTGTCTTCCTT
SOX2 ACACCAA TCCCA TCCACACT CCTCCCCAGGTTTTCTCTGT
KLF4 AGCCTAAATGATGGTGCTTGGT CCTTGTCAAAGTATGCAGCAGT
TFCP2L1 AGCTCAAAGTTGTCCTACTGCC TTCTAACCCAAGCACAGATCCC
SOX17(total) GAGCCAAGGGCGAGTCCCGTA CCTTCCACGACTTGCCCAGCAT
SOX17(endo) CCTGGGTTTTTGTTGTTGCT CCCCAAACTGTTCAAGTGG
BLIMP1(total) CTACCCTTATCCCGGAGAGC GGACATTCTTTGGGCAGAGT
BLIMP1(endo) CGGGGAGAATGTGGACTGGGTAGAG CTGGAGTTACACTTGGGGGCAGC
TFAP2C ATTAAGAGGATGCTGGGCTCTG CACTGTACTGCACACTCACCTT
NANOS3 CCCGAAACTCGGCAGGCAAGA AAGGCTCAGACTTCCCGGCAC
FOXA1 AAGGCATACGAACAGGCACTG TACACACCTTGGTAGTACGCC
FOXA2 ACCCGGTTTTATCCCTTGAATC ATACAACCTGCAACCAGACAGG
HNF1β CAATCCACTCTCAGGAGGCG ATCGTGGGAGAGGCATTGTG
T AGCCAAAGACAATCAGCAGAAA CACAAAAGGAGGGGCTTCACTA
MIXL1 TGCTTTCAAAACACTCGAGGAC GAGTGATCGAAGTAACAGGTGC
GSC GTCGAGAAAGAGGAACGAGGAG AAATACTACGGTGGGGGCTAGT
EVX1 CAAATCCTCACTCCCACACTCA GAAGAACCACTCCCTCTCAGTC
EOMES CAACATAAACGGACTCAATCCCA ACCACCTCTACGAACACATTGT
TBX6 AAGTACCAACCCCGCATACA TAGGCTGTCACGGAGATGAA
MESP1 GTGCTGGCTCTGTTGGAGA CTCGGTGCTCACAGAGACG
MESP2 AGCTTGGGTGCCTCCTTATT TGCTTCCCTGAAAGACATCA
SNAI1 CACTATGCCGCGCTCTTTC GGTCGTAGGGCTGCTGGAA
SNAI2 CAGACCCTGGTTGCTTCAA TGACCTGTCTGCAAATGCTC
Supplementary Table 3
